Sectors

Legend Holdings' Legend Star unit led a round for optical chip producer Turing Quantum sized above $15m while several Japanese companies also raised money.

Cambridge’s gene therapy developer had set terms for an offering set to raise between $135m and $149m on the Nasdaq Global Select Market.

The photonic computing technology spinout of MIT has now pocketed $113m in funding altogether.

The stem cell-transplant technology developer, partly based on Stanford research, is going public through a reverse merger that will give it a $490m market capitalisation.

The Meituan Dianping, Tencent and Swiss Re-backed health insurance marketplace operator priced its offering at the top of its range.

Existing investor Telkomsel provided the cash as on-demand ride provider Gojek prepares to seal a merger with e-commerce platform Tokopedia at an $18bn valuation.

Roche Venture Fund and Amgen will invest in the stem cell-transplant technology developer through a reverse merger transaction which will give it a $490m market capitalisation.

The Sanofi, Amgen, Alphabet, Novartis and PPD-backed clinical trials software producer is joining forces with publicly listed LifeSci Acquisition II Corp.

Kaiser Permanente has helped the parent company of in vitro diagnostics test provider ET Healthcare and biotechnology developer Gator Bio close its latest round.

The Fosun-backed gene therapy developer had set terms for an offering set to raise between $135m and $149m on the Nasdaq Global Select Market.

Lilly Asia Ventures was among the investors in a series B round for the renal disease treatment developer, which it incubated in 2018.